Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: JNK pathway inhibitors - Pharmascience

Drug Profile

Research programme: JNK pathway inhibitors - Pharmascience

Alternative Names: AEG 3482

Latest Information Update: 02 Jun 2011

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Aegera Therapeutics
  • Class Small molecules; Sulfonamides; Sulfones; Sulfoxides; Thiadiazoles
  • Mechanism of Action JNK mitogen-activated protein kinase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Cancer; Diabetic neuropathies; Neuropathic pain; Peripheral nervous system diseases

Most Recent Events

  • 25 Mar 2008 A lead compound from this programme has entered clinical development
  • 16 Mar 2007 Aegera Therapeutics initiates an accelerated screening programme to identify replacement compound(s) for AEG 33783
  • 11 Apr 2006 Data presented at the 231st ACS National Meeting (231st-ACS-2006) have been added to the Neurological disorders pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top